Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment

Objective This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients. Methods At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG), the Mini Mental Statu...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of geriatric psychiatry Vol. 24; no. 10; pp. 1094 - 1100
Main Authors Dierckx, E., Engelborghs, S., De Raedt, R., Van Buggenhout, M., De Deyn, P. P., Verté, D., Ponjaert-Kristoffersen, I.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.10.2009
Psychology Press
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients. Methods At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG), the Mini Mental Status Examination (MMSE), the Geriatric Depression Scale (GDS), a Dutch variation of Rey's Auditory Verbal Learning Test, the Memory Impairment Screen plus (MISplus) and the Visual Association Test (VAT) were administered to 40 patients diagnosed with MCI. After 18 months, MCI‐patients were reassessed and a follow‐up diagnosis was established. Of those who were seen for follow‐up (n = 31), seven fulfilled (NINCDS‐ADRDA) criteria of probable AD, while 24 did not convert. Results A binary logistic regression analysis showed that the MISplus contributed most to the prediction of conversion (OR = 0.28, 95% CI 0.099–0.790). With a cut‐off of 2 out of 6, a positive predictive value of 71.5%, a negative predictive value of 91.5% and an overall diagnostic accuracy of 87.0% were achieved. Conclusions This prospective, longitudinal study shows that a score of 0 or 1 out of 6 on the MISplus may be a good indicator of future (within 18 months) progression to AD among MCI‐patients. Copyright © 2009 John Wiley & Sons, Ltd.
Bibliography:Medical Research Foundation Antwerp
ark:/67375/WNG-HB8LQ8BW-5
istex:EB474B952B6F1D49AA31577F110AA05D0B68E0F5
The Institute for Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)
International Alzheimer's Research Foundation (IARF)
The Institute Born-Bunge
Thomas Riellaerts Research Fund
The Thomas Riellaerts Research Fund
The Agreement between the Institute Born-Bunge and the University of Antwerp
Research Fund of the Vrije Universiteit Brussel (OZR) and the Special Research Fund of the University of Antwerp
The Research Foundation-Flanders (FWO-F)
Neurosearch Antwerp
ArticleID:GPS2228
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0885-6230
1099-1166
DOI:10.1002/gps.2228